Azienda Ospedaliero-Universitaria Senese

Siena 53100

4 studies enrolling now · 13 studies all time

What they study most

Acute Major Bleeding, Acute Myeloid Leukemia, Adult Disease, Advanced Breast Cancer, Advanced Head and Neck Squamous Cell Carcinoma, Advanced Melanoma, Advanced Solid Tumor, Cardiovascular Diseases, Chronic Kidney Disease, Cutaneous Melanoma, Diffuse Large B-cell Lymphoma, Head and Neck Squamous Cell Carcinoma

Studies at this site

• L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC) — Recruiting now
• L19IL2/L19TNF in Patients With Cutaneous Squamous Cell Carcinoma — Recruiting now
• L19IL2/TNF in Patients With Basal Cell Carcinoma — Recruiting now
• Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF) — Recruiting now
• Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) — Running, not enrolling
• Study of OCTAPLEX in Patients With Acute Major Bleeding on DOAC Therapy With Factor Xa Inhibitor — Stopped early
• A Study of Daily Oral Orforglipron (LY3502970) Compared With Insulin Glargine in Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk — Completed
• A Study of Botensilimab (AGEN1181) for the Treatment of Advanced Melanoma — Running, not enrolling
• A Study to Evaluate the Safety and Efficacy of CyPep-1 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic Cancers — Completed
• Study of Magrolimab Combination Therapy in Patients With Head and Neck Squamous Cell Carcinoma — Stopped early
• A Study of ANV419 Alone or in Combination With Approved Treatment in Patients With Cutaneous Melanoma (OMNIA-1). — Completed
• A Study of Tilsotolimod in Combo With Ipilimumab vs Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma — Stopped early
• Efficacy Study for AC220 to Treat Acute Myeloid Leukemia (AML) — Completed